0001144204-14-047025.txt : 20140805 0001144204-14-047025.hdr.sgml : 20140805 20140805145316 ACCESSION NUMBER: 0001144204-14-047025 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140805 DATE AS OF CHANGE: 20140805 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Immune Design Corp. CENTRAL INDEX KEY: 0001437786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262007174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88256 FILM NUMBER: 141015799 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVE. E STREET 2: SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 682-0645 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVE. E STREET 2: SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: VACCSYS INC DATE OF NAME CHANGE: 20080617 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Topspin Fund, L.P. CENTRAL INDEX KEY: 0001615782 IRS NUMBER: 208367034 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: THREE EXPRESSWAY PLAZA CITY: ROSLYN HEIGHTS STATE: NY ZIP: 11577 BUSINESS PHONE: 516-625-9400 MAIL ADDRESS: STREET 1: THREE EXPRESSWAY PLAZA CITY: ROSLYN HEIGHTS STATE: NY ZIP: 11577 SC 13G 1 v385826_sc13g.htm FORM SC 13G

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Schedule 13G

 

Under the Securities Exchange Act of 1934

 

Immune Design Corp.

(Name of Issuer)

 

Common Stock, $0.001 par value

(Title of Class of Securities)

 

45252L103

(CUSIP Number)

 

July 26, 2014

(Date of Event Which Requires Filing of this Statement)

  

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

oRule 13d-1(b)
  
xRule 13d-1(c)
  
oRule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

  

 
 

 

1.

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Topspin Fund L.P.

 

 
2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) o

(b) o

3.

SEC USE ONLY

 

 
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

 

  5.

SOLE VOTING POWER

 

929,848

 

 

NUMBER OF

SHARES

BENEFICIALLY

6.

SHARED VOTING POWER

 

0

 

 

OWNED BY

EACH REPORTING

PERSON WITH

7.

SOLE DISPOSITIVE POWER

 

929,848

 

 
  8.

SHARED DISPOSITIVE POWER

 

 0

 

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

929,848

 

 
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
o
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.6%

 

 
12.

TYPE OF REPORTING PERSON

 

PN

 

 

 

 
 

 

Item 1(a).Name of Issuer:

 

Immune Design Corp.

 

Item 1(b).Address of Issuer’s Principal Executive Offices:

 

1616 Eastlake Ave. E., Suite 310, Seattle, Washington  98102

 

Item 2(a).Name of Person Filing:

 

Topspin Fund L.P. (20-8367043)

 

Item 2(b).Address of Principal Business Office or, if None, Residence:

 

Three Expressway Plaza, Roslyn Heights, NY 11577

 

Item 2(c).Citizenship:

 

Delaware

 

Item 2(d).Title of Class of Securities:

 

Common stock, $0.001 par value per share

 

Item 2(e).CUSIP Number:

 

45252L103

 

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

 

  (a) o Broker or dealer registered under Section 15 of the Exchange Act.

 

  (b) o Bank as defined in Section 3(a)(6) of the Exchange Act.

 

  (c) o Insurance company as defined in Section 3(a)(19) of the Exchange Act.

 

  (d) o Investment company registered under Section 8 of the Investment Company Act.

 

  (e) o An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

 

  (f) o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).

 

  (g) o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

 

  (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

 

  (i) o A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.

 

  (j) o Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

 
 

 

Item 4. Ownership.

 

  (a)

Amount beneficially owned:  

 

929,848

 

  (b)

Percent of class:  

 

5.6%

 

  (c) Number of shares as to which such person has:

 

  (i) Sole power to vote or to direct the vote:  929,848

 

  (ii) Shared power to vote or to direct the vote:  0

 

  (iii) Sole power to dispose or to direct the disposition of:  929,848

 

  (iv) Shared power to dispose or to direct the disposition of:  0

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9. Notice of Dissolution of Group.

 

Not applicable.

 

Item 10. Certifications.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 
 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

  

Date:  August 5, 2014   

TOPSPIN FUND L.P.

 

By: /s/ Leo Guthart

 
    Leo Guthart, Managing Member of the General Partner  

 

ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)